These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14755819)

  • 1. TOR of the cell cycle: Are there important implications for diabetics in the era of the drug-eluting stent?
    Carter AJ
    Catheter Cardiovasc Interv; 2004 Feb; 61(2):233-6. PubMed ID: 14755819
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing restenosis in early drug-eluting stent era: recent developments and future perspectives.
    Birkenhauer P; Yang Z; Gander B
    J Pharm Pharmacol; 2004 Nov; 56(11):1339-56. PubMed ID: 15525440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular radiation in a drug-eluting stent world: it's not over till it's over.
    Teirstein PS; King S
    Circulation; 2003 Jul; 108(4):384-5. PubMed ID: 12885730
    [No Abstract]   [Full Text] [Related]  

  • 5. Very late thrombosis after sirolimus-eluting stent implantation.
    Pasceri V; Pelliccia F; Cianfrocca C; Pristipino C; Santini M; Richichi G
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):438-42. PubMed ID: 16721209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New drug-eluting stents, optimizing technique, and the problem of drug-eluting stent restenosis.
    Vaina S; Ong AT; Serruys PW
    Minerva Cardioangiol; 2005 Oct; 53(5):341-60. PubMed ID: 16179880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive stent coatings in the drug-eluting era.
    Menown I; Lowe R; Penn I
    J Invasive Cardiol; 2005 Apr; 17(4):222-8. PubMed ID: 15831978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-eluting coronary stents].
    Fontos G
    Orv Hetil; 2006 Oct; 147(43):2059-66. PubMed ID: 17297752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting stent restenosis the pattern predicts the outcome.
    Cosgrave J; Melzi G; Biondi-Zoccai GG; Airoldi F; Chieffo A; Sangiorgi GM; Montorfano M; Michev I; Carlino M; Bonizzoni E; Colombo A
    J Am Coll Cardiol; 2006 Jun; 47(12):2399-404. PubMed ID: 16781366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting coronary stents.
    Salam AM; Al Suwaidi J; Holmes DR
    Curr Probl Cardiol; 2006 Jan; 31(1):8-119. PubMed ID: 16389102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stents: results, promises and problems.
    van der Hoeven BL; Pires NM; Warda HM; Oemrawsingh PV; van Vlijmen BJ; Quax PH; Schalij MJ; van der Wall EE; Jukema JW
    Int J Cardiol; 2005 Mar; 99(1):9-17. PubMed ID: 15721493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of drug-eluting stents: current best available evidence.
    Raja SG; Dreyfus GD
    J Card Surg; 2006; 21(6):605-12; discussion 613-4. PubMed ID: 17073969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents.
    Serruys PW; Daemen J
    Circulation; 2007 Mar; 115(11):1433-9; discussion 1439. PubMed ID: 17344323
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
    Grube E; Buellesfeld L
    Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent.
    Beijk MA; Piek JJ
    Expert Rev Med Devices; 2007 Jan; 4(1):11-21. PubMed ID: 17187467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Late stent thrombosis with drug eluting stents: disturbing signals on the radar].
    Hansen PR
    Ugeskr Laeger; 2007 Apr; 169(17):1561-3. PubMed ID: 17484825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
    Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
    Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent in patients with diabetes mellitus.
    Finn AV; Gold HK
    Circulation; 2004 Sep; 110(12):e318-9; author reply e318-9. PubMed ID: 15381668
    [No Abstract]   [Full Text] [Related]  

  • 19. Understanding the drug-eluting stent trials.
    Coolong A; Kuntz RE
    Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and predictors of recurrent restenosis following implantation of drug-eluting stents for in-stent restenosis.
    Lee CW; Park CB; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):104-8. PubMed ID: 17139669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.